LRQA is pleased to be taking part in the Biomarker Utilisation & Commercialisation Conference which is taking place from 10-11 September in London.
The event will explore the value of biomarkers from both a clinical and commercial perspectives. The aim is to help end-users to develop a comprehensive strategy for biomarker discovery, development, application and analysis in clinical trials.
Attendees will get to meet renowned biomarker experts to discuss and debate key issues in a friendly environment designed to encourage networking between participants.
The two-day programme explores a range of clinical and commercial factors affecting decision-makers in the biomarker industry, combined with the opportunity for interaction with key opinion leaders.
Industry expert Nick Baker, LRQA's Technical Manager for IVD, will be presenting on the following topic at the event:
Presentation: Assessment of Companion Diagnostics & Biomarkers Under the New IVD Regulation
Date: 11 September 2014
Time: 15.15 - 15.45
This presentation will cover how biomarkers and companion diagnostics will be classified under the new regulations and conformity assessment requirements for manufacturers. This is a great opportunity for you to find out how LRQA can help you meet your regulatory requirements.
To find out more about the event or to register to attend, please visit ACI